Course Information
9th International Symposium on Malignant Pleural Mesothelioma

UCLA Meyer & Renee Luskin Conference Center
Los Angeles, California
September 21, 2019
*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.





Download: [ PDF ]

Course Description

Malignant pleural mesothelioma (MPM) is an unusual cancer because it grows throughout the chest cavity as a diffuse process rather than a typical solid nodule or mass. Because of this unique characteristic, it has very specific treatment issues. MPM also is a rare tumor with less than 3,000 new cases annually, and therefore, most physicians, even pulmonologists and medical oncologists, typically only see these patients infrequently. Despite this, it is critical that all physicians involved in the care of MPM patients be familiar with the important issues in this disease and possess a thorough understanding regarding the tumor itself, its evaluation process, staging, treatment and the role of multidisciplinary management of these patients. This includes the role and extent of surgery as well as radiation, chemotherapy and newer targeted therapies and immunotherapy. Robert B. Cameron, MD, the course organizer and the Director of the UCLA Comprehensive Mesothelioma Program, has had over 30 years of experience with treating patients with MPM, including pleurectomy and decortication surgical procedures and a number of complementary adjuvant therapies with the goal of treating this deadly disease like a chronic illness, similar to hypertension and diabetes.

Registration Information

Enrollment

Online

To enroll click here.

By Mail

Enroll by mail with your American Express, Discover, MasterCard or Visa by using the form attached. Mail to:
UCLA Office of Continuing Medical Education
David Geffen School of Medicine at UCLA
Mesothelioma Symposium
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512

By Fax

Send the completed enrollment form with credit card information and your authorizing signature to (310) 794-2624.

By Phone

Call (310) 794-2620 to use your American Express, MasterCard, VISA, or Discover card.

Course Fees

Pre-registration fee (through September 5)
Physicians: $165
Nurses: $100
Families and Patients: $75
Students: $25*
Legal Profession: $450

Late registration fee (starting September 6)
Physicians: $225
Nurses: $150
Families and Patients: $100
Students: $40*
Legal Profession: $650

*Must show student ID on-site
Early registration is recommended, as space is limited.

Refunds

Cancellations must be received in writing by August 30, 2019 and will be subject to a $75 processing fee. No refunds will be given after that date. A full refund will be provided if for any reason the course must be cancelled or rescheduled.

Faculty

Course Chair

Robert B. Cameron, MD, FACS
Professor of Clinical Cardiothoracic Surgery and Surgical Oncology
Director, Comprehensive Mesothelioma Program
David Geffen School of Medicine at UCLA
Chief, Thoracic Surgery
West Los Angeles VA Medical Center
Los Angeles, California

International and Distinguished Faculty

Prasad S. Adusumilli, MD, FACS, FCCP

Deputy Chief and Attending (Tenured),
Thoracic Surgery
Director, Mesothelioma Program
Head, Solid Tumors Cell Therapy, Cellular
Therapeutics Center (CTC)
Memorial Sloan-Kettering Cancer Center
Professor, Cardiothoracic Surgery,
Weill Cornell Medical Center
New York, New York

Giovanni Luca Ceresoli, MD
Thoracic and GU Oncology Unit
Medical Onology Department
Cliniche Humanitas Gavazzeni
Bergamo, Italy

Chuong D. Hoang, MD, FACS
Thoracic Surgery Branch
Center for Cancer Research
National Cancer Institute, NIH
Bethesda, Maryland

Didier Jean, PhD
Centre de Recherche des Cordeliers –
Inserm UMRS 1138
Team Functional Genomics of Solid Tumors
(FunGeST)
Paris, France

Faculty

Olga Olevsky, MD
Health Sciences Assistant Clinical Professor
Santa Monica Oncology
David Geffen School of Medicine at UCLA
Santa Monica, California

Kevin Seals, MD
Fellow
Department of Radiology
David Geffen School of Medicine at UCLA

Masahide Tone, PhD
Director of Research, Senior Researcher
The Pacific Heart, Lung and Blood Institute
Los Angeles, California

Yukiko Tone, PhD
Senior Professor of Research
The Pacific Heart, Lung and Blood Institute
Los Angeles, California

Program Agenda

Program Schedule

Saturday, September 21, 2019

8:00

Registration and Breakfast

8:55

Welcome
Robert B. Cameron, MD, FACS

Morning Clinical Session I:
Moderators: Robert B. Cameron, MD, FACS & Olga Olevsky, MD

9:00

Mesothelioma: Surgery Update
Robert B. Cameron, MD, FACS

9:30

Medical Oncology Updates
Olga Olevsky, MD

10:00

CT, PET, MRI: Optional Imaging
Kevin Seals, MD

10:30

Discussion

10:45

Break

Morning Session II:
Moderator: Robert B. Cameron, MD, FACS

11:00

CAR T-Cell Therapy for Mesothelioma: Translation of Clinical Trials to Clinical Practice
Prasad S. Adusumilli, MD, FACS, FCCP

11:30

Tumor Treating Fields in MPM: Rationale, Current Results and Future Outlook
Giovanni Luca Ceresoli, MD

12:00

Long-Term Outcomes of Multi-Modality Therapy Including Percutaneous Cryoablation
Robert B. Cameron, MD, FACS

12:30

Discussion

12:45

Lunch

Afternoon Session I:
Moderators: Robert B. Cameron, MD, FACS & Masahide Tone, PhD

2:00

Immunological Environments in Mesothelioma Tumors
Yukiko Tone, PhD

2:30

Development of Mesothelioma Immunotherapy by Controlling Immunosuppressive Tumor Environment
Masahide Tone, PhD

3:00

Discussion

3:15

Mesothelioma Tumor Regression Via a Novel MicroRNA-Based Locoregional Therapy
Chuong D. Hoang, MD, FACS

3:45

Molecular Heterogeneity in Malignant Pleural Mesothelioma
Didier Jean, PhD

4:15

Discussion

4:30

Adjourn

 

Objectives

Course Objectives

At the completion of this course, participants should be able to:

  • Describe the roles of surgery, radiation, chemotherapy, and immunotherapy in the multidisciplinary treatment of malignant pleural mesothelioma
  • Compare PD blockade with CTLA blockade therapy and how they can complement each other
  • Assess the status of the immune tumor microenvironment
  • Describe novel potential biological and immunological therapies and their effects on malignant pleural mesothelioma
  • Describe the possible novel roles of CAR T cells in the treatment of mesothelioma

 

Target Audience

Mesothelioma experts who want to learn/share experiences about mesothelioma treatments.

Accreditation

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 6 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

Disclosures

Disclosure

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is truly independent and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We, at UCLA, fully endorse the letter and spirit of these concepts.

Miscellaneous

Location

UCLA Meyer & Renee Luskin Conference Center
425 Westwood Plaza
Los Angeles, CA 90095
855-522-8252

Local Accommmodations

Please note there are no room blocks reserved at any location. Any special rates are subject to change and subject to availability.
UCLA Meyer & Renee Luskin Conference Center
855-522-8252
Palomar Hotel
310-475-8711 (Ask for the UCLA rate)
The Beverly Hilton
310-274-7777 (Ask for the UCLA rate)

Directions and Parking

Self-parking in UCLA Lot 8
From the 405 freeway, exit Wilshire Blvd., East toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. Pay per license plate at the kiosk. Walk down one level and across pedestrian walkway toward Luskin Conference Center. Enter through Luskin Conference Center doors on right side. All day self-parking is $13.00 and overnight self-parking is $24 per night.